Skip to main
UNH

UnitedHealth Group (UNH) Stock Forecast & Price Target

UnitedHealth Group (UNH) Analyst Ratings

Based on 22 analyst ratings
Buy
Strong Buy 27%
Buy 59%
Hold 14%
Sell 0%
Strong Sell 0%

Bulls say

UnitedHealth Group is a strong and well-positioned company in the health insurance industry, with its Optum franchises helping it to achieve a dominant market position. Despite some challenges in the commercial and Medicaid segments, the company has reported strong quarterly results and raised its future guidance, indicating a positive outlook for its financial performance. It has a strong balance sheet and a focus on improving clinical quality and cost through various initiatives, and its medical loss ratio estimate has been lowered while its full-year earnings estimate has been raised. However, potential risks such as government exposure and competition should be closely monitored.

Bears say

UnitedHealth Group is facing pressures in its commercial cost trend due to the increased use of its IDR process by providers and higher billing intensity from fee-for-service providers. Additionally, specialty pharmaceuticals are also contributing to cost pressures. However, the company is actively integrating AI into its operations, which is expected to improve efficiency and reduce costs in the long term. Overall, UnitedHealth Group has a positive outlook for its Medicare Advantage plans and is expected to meet its long-term EPS growth target, driven in part by the growth of its Optum segment. The company also has strong cash flow and a solid balance sheet, providing flexibility for future investments and shareholder-friendly returns.

UnitedHealth Group (UNH) has been analyzed by 22 analysts, with a consensus rating of Buy. 27% of analysts recommend a Strong Buy, 59% recommend Buy, 14% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of UnitedHealth Group and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About UnitedHealth Group (UNH) Forecast

Analysts have given UnitedHealth Group (UNH) a Buy based on their latest research and market trends.

According to 22 analysts, UnitedHealth Group (UNH) has a Buy consensus rating as of Aug 8, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $454.09, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $454.09, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

UnitedHealth Group (UNH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.